Advertisement

Cell and Tissue Research

, Volume 322, Issue 2, pp 269–277 | Cite as

Induction of GH, PRL, and TSHβ mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line

  • Shunsuke Miyai
  • Shinichi Yoshimura
  • Yasumasa Iwasaki
  • Susumu Takekoshi
  • Ricardo V. Lloyd
  • Robert Yoshiyuki Osamura
Regular Article

Abstract

The functional development of pituitary cells depends on the expression of a combination of transcription factors and co-factors. Pituitary-specific transcription factor-1 (Pit-1) is required for the expression of growth hormone (GH), prolactin (PRL), and the thyroid-stimulating hormone β subunit (TSHβ) and acts synergistically with the estrogen receptor (ER) and GATA-binding protein 2 (GATA-2) to induce PRL and TSHβ expression, respectively. The glycoprotein hormone α subunit (αSU) is the first hormone to be expressed during pituitary development. In addition to being expressed in follicle-stimulating hormone, luteinizing hormone (LH), and TSH cells, αSU is reported to co-localize with GH in pituitary cells. These findings have led to the suggestion that the expression of Pit-1 in cells of the αSU-based gonadotropin cell lineage might also lead to the expression of GH. In this study, we transfected HP75 cells (derived from a human non-functioning pituitary adenoma that expressed αSU and LHβ) with Pit-1 by using an adenovirus FLAG-Pit-1 construct. Most of the transfected cells expressed GH mRNA, with fewer cells expressing PRL and TSHβ mRNA. The HP75 cells expressed the genes for ER and GATA-2, thus allowing their expression of GH, PRL, and TSHβ mRNA in response to Pit-1. These results support the hypothesis that GH can be induced in cells that possess an active αSU gene and shed light on the basic molecular mechanism that drives the development of GH, PRL, and TSHβ expression in the αSU-based gonadotroph lineage.

Keywords

Pituitary adenomas Differentiation Pit-1 Glycoprotein α subunit Transcription factor Human 

Abbreviations

αSU

glycoprotein hormone alpha subunit

GH

growth hormone

PRL

prolactin

TSH

thyroid-stimulating hormone

POMC

pro-opiomelanocortin

ACTH

adrenocorticotropic hormone

FSH

follicle-stimulating hormone

LH

luteinizing hormone

Pit-1

pituitary-specific transcription factor-1

ER

estrogen receptor

Tpit

pituitary cell-restricted T-box factor

NeuroD1

neurogenic differentiation 1

SF-1

steroidogenic factor 1

GATA-2

GATA-binding protein 2

DAX1

dosage-sensitive sex-reversal, adrenal hypoplasia congenital, X chromosome

Ptx1

pituitary homeobox 1

LHX3

LIM homeobox protein 3

Prop-1

Prophet of Pit-1

GHRH-R

growth hormone-releasing hormone receptor

References

  1. Asa SL, Kovacs K (1983) Histological classification of pituitary disease. Clin Endocrinol Metab 12:567–596PubMedCrossRefGoogle Scholar
  2. Barnhart KM, Mellon PL (1994) The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 8:878–885PubMedCrossRefGoogle Scholar
  3. Bertholon Gregoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519–527PubMedCrossRefGoogle Scholar
  4. Chang W, Zhou W, Theill LE, Baxter JD, Schaufele F (1996) An activation function in Pit-1 required selectively for synergistic transcription. J Biol Chem 271:17733–17738PubMedCrossRefGoogle Scholar
  5. Childs GV, Unabia G, Wu P (2000) Differential expression of growth hormone messenger ribonucleic acid by somatotropes and gonadotropes in male and cycling female rats. Endocrinology 141:1560–1570PubMedCrossRefGoogle Scholar
  6. Cohen LE (2000) Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 12:99–106CrossRefPubMedGoogle Scholar
  7. Dasen JS, Rosenfeld MG (2001) Signaling and transcriptional mechanisms in pituitary development. Annu Rev Neurosci 24:327–355PubMedCrossRefGoogle Scholar
  8. Felix I, Asa SL, Kovacs K, Horvath E, Smyth HS (1994) Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Arch Pathol Lab Med 118:66–70PubMedGoogle Scholar
  9. Furuhata S, Kameya T, Tsuruta T, Naritaka H, Toya S (1994) Colocalization of growth hormone (GH) and glycoprotein subunit alpha in GH-producing pituitary adenomas in acromegalic patients. Acta Neuropathol (Berl) 87:568–571CrossRefGoogle Scholar
  10. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA (1996) The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 10:1570–1581CrossRefPubMedGoogle Scholar
  11. Gessl A, Freissmuth M, Czech T, Matula C, Hainfellner JA, Buchfelder M, Vierhapper H (1994) Growth hormone-prolactin-thyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gs alpha protein. J Clin Endocrinol Metab 79:1128–1134CrossRefPubMedGoogle Scholar
  12. Gil del Alamo P, Pettersson KS, Saccomanno K, Spada A, Faglia G, Beck Peccoz P (1994) Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Clin Endocrinol (Oxf) 41:661–666Google Scholar
  13. Gordon DF, Lewis SR, Haugen BR, James RA, McDermott MT, Wood WM, Ridgway EC (1997) Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem 272:24339–24347CrossRefPubMedGoogle Scholar
  14. Horn F, Windle JJ, Barnhart KM, Mellon PL (1992) Tissue-specific gene expression in the pituitary: the glycoprotein hormone alpha-subunit gene is regulated by a gonadotrope-specific protein. Mol Cell Biol 12:2143–2153PubMedGoogle Scholar
  15. Horvath E, Lloyd RV, Kovacs K (1990) Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 63:511–520PubMedGoogle Scholar
  16. Ingraham HA, Albert VR, Chen RP, Crenshaw EB III, Elsholtz HP, He X, Kapiloff MS, Mangalam HJ, Swanson LW, Treacy MN, et al (1990) A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol 52:773–791CrossRefPubMedGoogle Scholar
  17. Jin L, Kulig E, Qian X, Scheithauer BW, Eberhardt NL, Lloyd RV (1998) A human pituitary adenoma cell line proliferates and maintains some differentiated functions following expression of SV40 T-antigen. Endocr Pathol 9:169–184CrossRefGoogle Scholar
  18. Jong MT, Raaka BM, Samuels HH (1994) A sequence in the rat Pit-1 gene promoter confers synergistic activation by glucocorticoids and protein kinase-C. Mol Endocrinol 8:1320–1327CrossRefPubMedGoogle Scholar
  19. Kovacs K (1991) The pathology of clinically non-functioning pituitary adenomas. Pathol Res Pract 187:571–573PubMedGoogle Scholar
  20. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV (1996) The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 78:502–510CrossRefPubMedGoogle Scholar
  21. Kurotani R, Yoshimura S, Iwasaki Y, Inoue K, Teramoto A, Osamura RY (2002) Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. J Endocrinol 172:477–487PubMedCrossRefGoogle Scholar
  22. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104:849–859PubMedCrossRefGoogle Scholar
  23. Lanctot C, Gauthier Y, Drouin J (1999) Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 140:1416–1422CrossRefPubMedGoogle Scholar
  24. Lefevre C, Imagawa M, Dana S, Grindlay J, Bodner M, Karin M (1987) Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor. EMBO J 6:971–981PubMedGoogle Scholar
  25. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528–533PubMedCrossRefGoogle Scholar
  26. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L, Nelson C, Elsholtz H, Rosenfeld MG (1989) A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946–958PubMedCrossRefGoogle Scholar
  27. Mukdsi JH, De Paul AL, Munoz S, Aoki A, Torres AI (2004) Immunolocalization of Pit-1 in gonadotroph nuclei is indicative of the transdifferentiation of gonadotroph to lactotroph cells in prolactinomas induced by estrogen. Histochem Cell Biol 121:453–462CrossRefPubMedGoogle Scholar
  28. Nelson C, Albert VR, Elsholtz HP, Lu LI, Rosenfeld MG (1988) Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 239:1400–1405PubMedCrossRefGoogle Scholar
  29. Niiori Onishi A, Iwasaki Y, Mutsuga N, Oiso Y, Inoue K, Saito H (1999) Molecular mechanisms of the negative effect of insulin-like growth factor-I on growth hormone gene expression in MtT/S somatotroph cells. Endocrinology 140:344–349CrossRefPubMedGoogle Scholar
  30. Osamura RY, Watanabe K (1987) Immunohistochemical colocalization of growth hormone (GH) and alpha subunit in human GH secreting pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 411:323–330PubMedCrossRefGoogle Scholar
  31. Osamura RY, Tahara S, Komatsubara K, Itoh Y, Kajiwara H, Kurotani R, Sanno N, Teramoto A (1999) Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage? Pituitary 1:269–271CrossRefPubMedGoogle Scholar
  32. Oyama K, Sanno N, Teramoto A, Osamura RY (2001) Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Mod Pathol 14:892–899PubMedCrossRefGoogle Scholar
  33. Palomino T, Sanchez Pacheco A, Pena P, Aranda A (1998) A direct protein-protein interaction is involved in the cooperation between thyroid hormone and retinoic acid receptors and the transcription factor GHF-1. FASEB J 12:1201–1209PubMedGoogle Scholar
  34. Poulin G, Turgeon B, Drouin J (1997) NeuroD1/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 17:6673–6682PubMedGoogle Scholar
  35. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE (1992) A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115–1118PubMedCrossRefGoogle Scholar
  36. Sanno N, Teramoto A, Matsuno A, Itoh J, Takekoshi S, Osamura RY (1996) In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas. Acta Neuropathol (Berl) 91:263–268CrossRefGoogle Scholar
  37. Sanno N, Jin L, Qian X, Osamura RY, Scheithauer BW, Kovacs K, Lloyd RV (1997) Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries. J Clin Endocrinol Metab 82:1974–1982CrossRefPubMedGoogle Scholar
  38. Sanno N, Tahara S, Kurotani R, Matsuno A, Teramoto A, Osamura RY (2001a) Cytochemical and molecular biological aspects of the pituitary and pituitary adenomas—cell differentiation and transcription factors. Prog Histochem Cytochem 36:263–299PubMedGoogle Scholar
  39. Sanno N, Teramoto A, Osamura RY (2001b) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neuro-Oncol 54:179–186CrossRefGoogle Scholar
  40. Sano T, Yamada S (1994) Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Pathol Int 44:697–703PubMedCrossRefGoogle Scholar
  41. Shull JD, Gorski J (1984) Estrogen stimulates prolactin gene transcription by a mechanism independent of pituitary protein synthesis. Endocrinology 114:1550–1557PubMedCrossRefGoogle Scholar
  42. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW (1990) Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 4:695–711PubMedCrossRefGoogle Scholar
  43. Suhardja A, Kovacs K, Rutka J (2001) Role of transcription factors in the pathogenesis of pituitary adenomas: a review. J Neuro-Oncol 55:185–193CrossRefGoogle Scholar
  44. Thapar K, Kovacs K, Laws ER (1995a) The classification and molecular biology of pituitary adenomas. Adv Tech Stand Neurosurg 22:3–53PubMedGoogle Scholar
  45. Thapar K, Kovacs K, Muller PJ (1995b) Clinical-pathological correlations of pituitary tumours. Baillieres Clin Endocrinol Metab 9:243–270CrossRefPubMedGoogle Scholar
  46. Tremblay JJ, Viger RS (2001) GATA factors differentially activate multiple gonadal promoters through conserved GATA regulatory elements. Endocrinology 142:977–986CrossRefPubMedGoogle Scholar
  47. Tremblay JJ, Lanctot C, Drouin J (1998) The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 12:428–441CrossRefPubMedGoogle Scholar
  48. Umeoka K, Sanno N, Osamura RY, Teramoto A (2002) Expression of GATA-2 in human pituitary adenomas. Mod Pathol 15:11–17CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2005

Authors and Affiliations

  • Shunsuke Miyai
    • 1
  • Shinichi Yoshimura
    • 2
  • Yasumasa Iwasaki
    • 3
  • Susumu Takekoshi
    • 1
  • Ricardo V. Lloyd
    • 4
  • Robert Yoshiyuki Osamura
    • 1
  1. 1.Department of PathologyTokai University School of MedicineKanagawaJapan
  2. 2.Department of Molecular Life ScienceTokai University School of MedicineKanagawaJapan
  3. 3.Department of Internal MedicineKochi University School of MedicineKochiJapan
  4. 4.Department of Laboratory Medicine and PathologyMayo Clinic and Mayo FoundationRochester, MNUSA

Personalised recommendations